Providence Cancer Institute
Background data
Program Type : Adult ProgramFACT Approved: Yes
Year CAR T-cell Therapy Program Opened:
Location Info
Providence Cancer InstituteProvidence Hematologic Malignancies Program
4805 NE Glisan Street, Suite 1N29
Portland, , 97213
Portland, , 97213
Website : https://www.providence.org/locations/or/cancer-institute/personalized-cancer-care/autologous-stem-cell-transplant-program
CAR T-cell therapies performed
Numbers displayed are the most recent data provided by this center.| Year | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Number performed | - | 4 | 10 | 12 | 13 |
Program Director
| Name | Phone |
|---|---|
| Roxanne Payne, MN, FNP, AOCNP | (503) 215-6737 |
Medical Director
| Name | Phone |
|---|---|
| Stacy Lewis, MD | (503) 216-6300 |
Physician
| Name | Phone |
|---|---|
| Hugo Akabane, MD | (503) 215-5696 |
| Natasha Edwin, MD | (503) 216-6300 |
| Christie Moore, DO | (503) 216-6300 |
Coordinator
| Name | Phone |
|---|---|
| Ian Malkasian, RN, BSN, OCN | (503) 215-8646 |
Diseases treated by CAR T-cell therapy
- Lymphoma
- Multiple Myeloma
CAR T-Cell products
- Abecma (idecabtagene vicleucil, ide-cel)
- Breyanzi (lisocabtagene maraleucel, liso-cel)